This provider's $20.5M in total Medicare payments ranks in the 95th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 981% from 2019 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 573% in 2020
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2019 | $951.37 | $743.02 | 1.28x | $208.35 | $717.0K | 965 | 4 |
| 2020 | $837.26 | $628.94 | 1.33x | $208.32 | $4.8M | 7.7K | 16 |
| 2021 | $670.76 | $523.47 | 1.28x | $147.29 | $5.1M | 9.7K | 30 |
| 2022 | $57.89 | $50.69 | 1.14x | $7.20 | $2.2M | 42.7K | 15 |
| 2023 | $12.13 | $11.89 | 1.02x | $0.24 | $7.8M | 652.2K | 5 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 692.3K | $8.1M | $11.76 | 1.02x |
| 81408 | Molecular pathology procedure level 9 | 2.3K | $4.7M | $2.0K | 1.30x |
| 81162 | Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants | 533 | $972.0K | $1.8K | 1.37x |
| 81317 | Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis | 1.4K | $909.3K | $671.56 | 1.33x |
| 81407 | Molecular pathology procedure level 8 | 917 | $771.9K | $841.80 | 1.30x |
| 81404 | Molecular pathology procedure level 5 | 2.3K | $619.3K | $273.55 | 1.45x |
| 81405 | Molecular pathology procedure level 6 genetic analysis | 2.0K | $590.0K | $299.82 | 1.33x |
| 81406 | Molecular pathology procedure level 7 | 2.0K | $575.9K | $281.49 | 1.41x |
| 81201 | Gene analysis (adenomatous polyposis coli), full gene sequence | 585 | $452.6K | $773.75 | 1.03x |
| 81435 | Test for detecting genes associated with colon cancer, genomic sequence analysis panel, at least 10 genes | 737 | $433.6K | $588.36 | 1.36x |
| 81307 | Gene analysis (partner and localizer of brca2) full sequence analysis | 634 | $425.4K | $670.97 | 1.04x |
| 81298 | Gene analysis (muts homolog 6 [e coli]) full sequence analysis | 643 | $409.3K | $636.55 | 1.09x |
| 81295 | Gene analysis (muts homolog 2, colon cancer, nonpolyposis type 1) full sequence analysis | 622 | $235.5K | $378.54 | 1.05x |
| 81249 | Gene analysis (glucose-6-phosphate dehydrogenase) full sequence analysis | 309 | $184.7K | $597.57 | 1.17x |
| 81403 | Molecular pathology procedure level 4 | 935 | $172.6K | $184.55 | 1.08x |
| 81308 | Gene analysis (partner and localizer of brca2) for detection of known familial variant | 425 | $128.1K | $301.35 | 1.33x |
| 81321 | Gene analysis (phosphatase and tensin homolog), full sequence analysis | 133 | $79.1K | $594.95 | 1.17x |
| 81401 | Molecular pathology procedure level 2 | 554 | $75.9K | $137.00 | 1.88x |
| 81230 | Gene analysis (cytochrome p450 family 3 subfamily a member 4) for common variant | 394 | $68.9K | $174.81 | 1.14x |
| 81231 | Gene analysis (cytochrome p450 family 3 subfamily a member 5) for common variant | 394 | $68.9K | $174.81 | 1.14x |
This provider submits charges 1.18 times higher than what Medicare actually pays.
A markup ratio of 1.18x means for every $100 Medicare pays, this provider initially charges $118. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data